JP2012505017A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505017A5
JP2012505017A5 JP2011530993A JP2011530993A JP2012505017A5 JP 2012505017 A5 JP2012505017 A5 JP 2012505017A5 JP 2011530993 A JP2011530993 A JP 2011530993A JP 2011530993 A JP2011530993 A JP 2011530993A JP 2012505017 A5 JP2012505017 A5 JP 2012505017A5
Authority
JP
Japan
Prior art keywords
actuator
cavity
inhaler
ethyl
inhaler according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011530993A
Other languages
English (en)
Japanese (ja)
Other versions
JP5518082B2 (ja
JP2012505017A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2009/051110 external-priority patent/WO2010042033A1/en
Publication of JP2012505017A publication Critical patent/JP2012505017A/ja
Publication of JP2012505017A5 publication Critical patent/JP2012505017A5/ja
Application granted granted Critical
Publication of JP5518082B2 publication Critical patent/JP5518082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011530993A 2008-10-08 2009-10-07 吸入装置および医薬を投与する方法 Expired - Fee Related JP5518082B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10360608P 2008-10-08 2008-10-08
US61/103,606 2008-10-08
PCT/SE2009/051110 WO2010042033A1 (en) 2008-10-08 2009-10-07 Inhalation device and method of dispensing medicament

Publications (3)

Publication Number Publication Date
JP2012505017A JP2012505017A (ja) 2012-03-01
JP2012505017A5 true JP2012505017A5 (enExample) 2012-11-29
JP5518082B2 JP5518082B2 (ja) 2014-06-11

Family

ID=42100804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011530993A Expired - Fee Related JP5518082B2 (ja) 2008-10-08 2009-10-07 吸入装置および医薬を投与する方法

Country Status (17)

Country Link
US (1) US9095670B2 (enExample)
EP (1) EP2334358B1 (enExample)
JP (1) JP5518082B2 (enExample)
KR (1) KR20110074766A (enExample)
CN (1) CN102245239B (enExample)
AU (1) AU2009302956B8 (enExample)
BR (1) BRPI0920658A2 (enExample)
CA (1) CA2738822A1 (enExample)
CL (1) CL2011000789A1 (enExample)
EA (1) EA019293B1 (enExample)
ES (1) ES2579902T3 (enExample)
IL (1) IL212074A0 (enExample)
MX (1) MX2011003759A (enExample)
NZ (1) NZ591956A (enExample)
UA (1) UA101056C2 (enExample)
WO (1) WO2010042033A1 (enExample)
ZA (1) ZA201103334B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005057685A1 (de) * 2005-12-01 2007-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
US9889087B2 (en) * 2014-06-10 2018-02-13 The Board Of Trustees Of The Leland Stanford Junior University Intranasal delivery of β2-adrenergic receptor agonists for improving cognition in humans with down syndrome and compositions therefor
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
EP3939591A1 (en) 2016-06-27 2022-01-19 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
GB2553534A (en) * 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechanism for an inhaler
GB201615186D0 (en) * 2016-09-07 2016-10-19 3M Innovative Properties Co Energy storage mechanism for an inhaler
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
BR112019019107A2 (pt) 2017-03-15 2020-04-22 Csp Technologies Inc inalador e métodos de uso e produção do mesmo
CN110271772B (zh) * 2018-03-13 2023-09-15 李和伟 一种给药器
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
JP7504088B2 (ja) 2018-10-16 2024-06-21 ジョージア ステイト ユニバーシティー リサーチ ファウンデーション インコーポレイテッド 医学的障害の治療のための一酸化炭素プロドラッグ
US11253035B2 (en) 2019-01-22 2022-02-22 Coopervision International Holding Company, Lp Blister package for contact lens
US11267643B2 (en) 2019-01-22 2022-03-08 Coopervision International Limited Contact lens dispenser
US11136176B2 (en) 2019-01-22 2021-10-05 Coopervision International Limited Contact lens blister package with lens cradle
US11419397B2 (en) 2019-01-22 2022-08-23 Coopervision International Limited Push-up contact lens blister package
US11229266B2 (en) 2019-01-22 2022-01-25 Coopervision International Limited Tessellating blister packages for contact lenses
US12053069B2 (en) 2019-01-22 2024-08-06 Coopervision International Limited Contact lens blister package with double layer foil component
EP4603484A2 (en) 2019-12-19 2025-08-20 Georgia State University Research Foundation, Inc. Compounds for the treatment of bacterial infections and potentiation of antibiotics
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
EP4216946A4 (en) 2020-09-23 2024-11-13 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024760D0 (en) 1990-11-14 1991-01-02 Riker Laboratories Inc Inhalation device and medicament carrier
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5823183A (en) 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
ES2167987T3 (es) 1996-01-03 2002-05-16 Glaxo Group Ltd Dispositivo inhalador.
ATE432727T1 (de) 1997-12-02 2009-06-15 Valois Sas Trockenpulverinhalator
NL1008031C2 (nl) * 1998-01-15 1999-07-21 Pharmachemie Bv Inrichting voor het inhaleren van medicament.
GB9905538D0 (en) 1999-03-10 1999-05-05 Glaxo Group Ltd A device
AU1068401A (en) 1999-10-12 2001-04-23 Shl Medical Ab Inhaler
US7171965B2 (en) 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
WO2001072605A1 (en) 2000-03-27 2001-10-04 Dura Pharmaceuticals, Inc. Containers for individual doses of an inhalable pharmaceutical
SE517227C2 (sv) 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
GB0120018D0 (en) * 2001-08-16 2001-10-10 Meridica Ltd Pack containing medicament and dispensing device
JP4261351B2 (ja) 2001-09-19 2009-04-30 アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド 吸入器
US6941947B2 (en) 2002-12-18 2005-09-13 Quadrant Technologies Limited Unit dose dry powder inhaler
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
GB0322544D0 (en) * 2003-09-26 2003-10-29 Innovata Biomed Ltd Apparatus
SE0401654D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament
GB0426780D0 (en) * 2004-12-07 2005-01-12 3M Innovative Properties Co Pressurized inhalation devices
CA2606493A1 (en) * 2005-05-02 2006-11-09 Astrazeneca Ab An arrangement and a method for opening a cavity, a medical package and a dispensing device
KR20090030347A (ko) 2006-07-19 2009-03-24 아스트라제네카 아베 신규 트리시클릭 스피로피페리딘 화합물, 이들의 합성 및 이들의 케모킨 수용체 활성의 조절제로서의 용도
WO2008101992A1 (en) 2007-02-21 2008-08-28 Novo Nordisk A/S Aerosol generating device with air flow control
GB0704928D0 (en) 2007-03-14 2007-04-25 Cambridge Consultants Dry powder inhalers
EP2142239B1 (en) * 2007-04-30 2017-06-07 Sun Pharma Advanced Research Company Limited Inhalation device
WO2009008832A1 (en) 2007-07-12 2009-01-15 Astrazeneca Ab Medicament containing structure, method and inhalation device comprising such structure
CA2712603A1 (en) * 2008-02-12 2009-08-20 Astrazeneca Ab Inhaler comprising a base having at least one sealed cavity containing medicament
BRPI0907713A2 (pt) * 2008-02-12 2015-07-21 Astrazeneca Ab Inalador compreendendo uma base possuindo uma pluralidade de cavidades seladas contendo medicamento
US9155851B2 (en) * 2008-10-08 2015-10-13 Astrazeneca Ab Breath activated inhaler
US20110253138A1 (en) * 2008-10-08 2011-10-20 Astrazeneca Ab Inhaler with audible indicator means

Similar Documents

Publication Publication Date Title
JP2012505017A5 (enExample)
JP2013532504A5 (enExample)
RU2013104024A (ru) Ингалятор
JP2012505020A5 (enExample)
JP2012505018A5 (enExample)
JP5518082B2 (ja) 吸入装置および医薬を投与する方法
JP5308157B2 (ja) 吸入器
US20140000601A1 (en) Inhaler
JP2012505019A5 (enExample)
AU2009302959B2 (en) Inhaler with audible indicator means
RU2011115404A (ru) Активируемый дыханием ингалятор
RU2011113440A (ru) Ингалятор с дискретным перемещением, связанным с перемещением крышки
WO2001028616A1 (en) Medicament pack
EA032398B1 (ru) Порошковый ингалятор и его приводной механизм
RU2011152515A (ru) Устройство раздачи и способ увеличения порошкообразного средства в поток воздуха
JP2012531961A5 (enExample)
JP2013523377A (ja) 乾燥粉末吸入器のマウスピースボタン
KR20150030256A (ko) 약물 전달 기구를 위한 배열
WO2009102274A1 (en) Inhaler comprising a base having at least one sealed cavity containing medicament